Infinity Q founder sentenced to 15 years for fraud scheme
By 
Adrianne Appel2023-04-12T21:48:00
The former chief investment officer and founder of investment adviser Infinity Q Capital Management was sentenced to 15 years in prison and ordered to forfeit $22 million for artificially inflating the values of certain derivatives to defraud investors.
James Velissaris employed a small staff that included a chief compliance and risk officer accused of assisting in his fraud, the Department of Justice noted in its press release Monday. The CCO, Scott Lindell, was charged by the Securities and Exchange Commission (SEC) regarding his alleged role in September.
The actions of Velissaris inflated the value of Infinity Q funds by more than $1 billion, the SEC said.
Related articles
-
News BriefIRB Brasil to pay shareholders $5M over CFO’s claims
Brazilian reinsurance company IRB Brasil RE agreed to pay $5 million to harmed investors after its former chief financial officer allegedly lied about Berkshire Hathaway investing in the company.
-
News BriefDOJ: Disbarred attorney serving as bank CCO charged for fraud role
The Department of Justice announced charges against the “purported” chief compliance officer at Dominion Bank and Trust Company Limited for allegedly taking part in a $4 million fraud scheme.
-
News Brief
DOJ: Former Magellan quality control director, execs misled public over lead tests
The former director of quality assurance at Magellan Diagnostics allegedly conspired with executives to conceal a critical flaw in lead tests they knew would result in tens of thousands of false negative tests among lead-exposed children.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”